GlassScriptPhysician profile
Brent P Keith
NPI 1285804971
$2,095.34
in general payments reported to CMS, 2019-2025
19 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $200 · 2021: $251 · 2022: $369 · 2023: $387 · 2024: $267 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $744.16 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $271.46 | 2022-2025 | Dupixent |
| Travere Therapeutics, INC. | $223.20 | 2019-2022 | |
| Genzyme Corporation | $168.14 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $142.04 | 2023-2025 | Eohilia, Gattex |
| Cumberland Pharmaceuticals, INC. | $108.81 | 2022-2025 | Kristalose |
| Medtronic, INC. | $86.34 | 2024-2025 | Pillcam, Gi Genius |
| Alexion Pharmaceuticals, INC. | $73.08 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $72.07 | 2022-2023 | |
| Qol Medical, LLC | $55.41 | 2024-2025 | Sucraid, Sucraid |
| Albireo Pharma, INC. | $33.79 | 2022 | |
| Acadia Pharmaceuticals INC | $20.58 | 2025 | Daybue |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.95 | 2024 | Cyltezo |
| Shire North American Group INC | $17.75 | 2019 | |
| Phadia US INC. | $17.04 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.39 | 2020 | |
| Horizon Therapeutics Plc | $14.56 | 2019 | |
| Janssen Biotech, INC. | $11.57 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Keith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.